small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
  1. Insights & News

Article

New Patent-Defense Path for Pharma

  • PDFPDF
    • Email
    • LinkedIn
    • Facebook
    • Twitter
    Share this page
  • PDFPDF
    • Email
    • LinkedIn
    • Facebook
    • Twitter
    Share this page

Article

New Patent-Defense Path for Pharma

  • PDFPDF
    • Email
    • LinkedIn
    • Facebook
    • Twitter
    Share this page

Less Than 1 Min Read

Author

David P. Dalke, Ph.D.

Related Locations

Los Angeles

Related Topics

Patent Litigation
Pharmaceuticals
Inter Partes Review (IPR)
Patent Trial and Appeal Board (PTAB)

Related Capabilities

Patent Litigation
Medical Devices

October 2014

Just over three years ago, Congress enacted the America Invents Act, hailed as "one of the most significant legislative reforms to the patent system in our Nation's history." The Act included several sweeping changes, including advent of Inter Partes Review (IPR)—a new litigation procedure held before the Patent Trial and Appeal Board (PTAB) to challenge the validity of patent claims. Designed to be a faster and less expensive alternative to district court litigation, IPRs have taken the patent bar by storm.

View the article.

Related Professionals

Related Professionals

David P. Dalke, Ph.D.

David P. Dalke, Ph.D.

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising